NSECertificate under SEBI (Depositories and Participants) Regulations, 2018Results10 Jul 2026
Windlas Biotech Limited
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Windlas Biotech Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 for the Quarter ended June 30, 2026.
NSEAnalysts/Institutional Investor Meet/Con. Call Updates9 Jul 2026
Windlas Biotech Limited
Analysts/Institutional Investor Meet/Con. Call Updates
Windlas Biotech Limited has informed the Exchange about the schedule of an analyst/institutional investor meeting, to be held virtually on July 14, 2026, where the company will discuss publicly available documents and not share any unpublished price-sensitive information.
NSEGeneral UpdatesResults2 Jul 2026
Windlas Biotech Limited
General Updates
Windlas Biotech Limited has informed the Exchange about completion of despatch of Notice of 25th AGM and the Annual Report for FY26.
NSEGeneral UpdatesResults1 Jul 2026
Windlas Biotech Limited
General Updates
Windlas Biotech Limited has informed the Exchange about record date/cut-off date for the purpose of AGM. The company has fixed July 16, 2026 as the cut-off date for ascertaining the names of members who will be entitled to cast their votes electronically during July 20, 2026 to July 22, 2026, and also during AGM in respect of business to be transacted at the aforesaid AGM and for the purpose of receiving dividend, if any.
NSEShareholders meetingshareholders_meeting1 Jul 2026
Windlas Biotech Limited
Shareholders meeting
Windlas Biotech Limited has informed the Exchange about the Annual General Meeting to be held on July 23, 2026, to consider and pass various resolutions, including the ratification of the remuneration of the Cost Auditors, appointment of a Director, and declaration of a Final Dividend.
NSERecord DateDividend1 Jul 2026
Windlas Biotech Limited
Record Date
Windlas Biotech Limited has announced the record date for the purpose of dividend for the financial year 2025-26 as July 16, 2026, and has recommended a dividend of Rs. 6.30 per equity share.
NSEAnalysts/Institutional Investor Meet/Con. Call Updates26 Jun 2026
Windlas Biotech Limited
Analysts/Institutional Investor Meet/Con. Call Updates
Windlas Biotech Limited has informed the Exchange about a scheduled analyst/institutional investor meeting on July 7, 2026, where the company will discuss publicly available documents and no unpublished price-sensitive information will be shared.
NSETrading WindowRegulatory25 Jun 2026
Windlas Biotech Limited
Trading Window
Windlas Biotech Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, from July 1, 2026, till the expiry of 48 hours after the unaudited financial results of the Company for the quarter ended June 30, 2026, becomes generally available information.